Literature DB >> 33442728

ACE/ACE2 balance might be instrumental to explain the certain comorbidities leading to severe COVID-19 cases.

Sarbashri Bank1,2, Subrata Kumar De3, Biswabandhu Bankura4, Smarajit Maiti5, Madhusudan Das4, Gausal A Khan6.   

Abstract

The outbreak of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a global catastrophe. The elderly and people with comorbidity are facing a serious complication of the disease. The entry and infection strategy of SARS-CoV-2 in a host cell is raised by an amazing way of angiotensin-converting enzyme (ACE) 2 (ACE2) receptor recognition and imbalance of ACE/ACE2 in various organs, especially in the lungs. Here it has been discussed the role of interferon and protease during the receptor recognition (begining of infection) and followed by the impact of cytokine and hypoxia in the context of the balance of ACE/ACE2. It has also very concisely delineated the biochemistry and mechanism of ACE/ACE2 balance in different stages of infection and its role in comorbidity.
© 2021 The Author(s).

Entities:  

Keywords:  ACE/ACE2; Comorbidity; Hypoxia; SARS-CoV-2

Year:  2021        PMID: 33442728     DOI: 10.1042/BSR20202014

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  5 in total

1.  Testosterone as a Biomarker of Adverse Clinical Outcomes in SARS-CoV-2 Pneumonia.

Authors:  Lorenzo Marinelli; Guglielmo Beccuti; Marco Zavattaro; Serena Cagnina; Iacopo Gesmundo; Chiara Bona; Chiara Lopez; Silvia Scabini; Francesca Canta; Simone Mornese Pinna; Tommaso Lupia; Cataldo Di Bisceglie; Federico Ponzetto; Fabio Settanni; Francesco Giuseppe De Rosa; Ezio Ghigo; Giovanna Motta
Journal:  Biomedicines       Date:  2022-03-31

2.  A new chapter for a better Bioscience Reports.

Authors:  Christopher D O Cooper; Weiping Han
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

3.  Lack of Correlation Between Soluble Angiotensin-Converting Enzyme 2 and Inflammatory Markers in Hospitalized COVID-19 Patients with Hypertension.

Authors:  Melva Louisa; Daniel Cahyadi; Dina Nilasari; Vivian Soetikno
Journal:  Infect Drug Resist       Date:  2022-08-24       Impact factor: 4.177

4.  The Altered Anatomical Distribution of ACE2 in the Brain With Alzheimer's Disease Pathology.

Authors:  Huan Cui; Si Su; Yan Cao; Chao Ma; Wenying Qiu
Journal:  Front Cell Dev Biol       Date:  2021-06-25

5.  Structural insights revealed by crystal structure of B38-CAP, an isoenzyme of carboxypeptidase ACE2, the receptor of SARS-CoV-2.

Authors:  Peiyuan Liu; Yanfeng Zhang; Zibin Li; Jianwen Huang; Tao Wang; Cheng Chen
Journal:  Biochem Biophys Res Commun       Date:  2022-03-18       Impact factor: 3.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.